108 related articles for article (PubMed ID: 9616287)
21. The exon 13 duplication in the BRCA1 gene is a founder mutation present in geographically diverse populations. The BRCA1 Exon 13 Duplication Screening Group.
The BRCA1 Exon 13 Duplication Screening Group
Am J Hum Genet; 2000 Jul; 67(1):207-12. PubMed ID: 10827109
[TBL] [Abstract][Full Text] [Related]
22. Comprehensive analysis of 989 patients with breast or ovarian cancer provides BRCA1 and BRCA2 mutation profiles and frequencies for the German population.
Meindl A;
Int J Cancer; 2002 Feb; 97(4):472-80. PubMed ID: 11802209
[TBL] [Abstract][Full Text] [Related]
23. Mutation analysis of the BRCA1 and BRCA2 genes in the Belgian patient population and identification of a Belgian founder mutation BRCA1 IVS5 + 3A > G.
Claes K; Machackova E; De Vos M; Poppe B; De Paepe A; Messiaen L
Dis Markers; 1999 Oct; 15(1-3):69-73. PubMed ID: 10595255
[TBL] [Abstract][Full Text] [Related]
24. BRCA1 screening in patients with a family history of breast or ovarian cancer.
Arver B; Claro A; Langerød A; Børresen-Dale AL; Lindblom A
Genet Test; 1999; 3(2):223-6. PubMed ID: 10464672
[TBL] [Abstract][Full Text] [Related]
25. Molecular and genealogical characterization of the R1443X BRCA1 mutation in high-risk French-Canadian breast/ovarian cancer families.
Vézina H; Durocher F; Dumont M; Houde L; Szabo C; Tranchant M; Chiquette J; Plante M; Laframboise R; Lépine J; Nevanlinna H; Stoppa-Lyonnet D; Goldgar D; Bridge P; Simard J
Hum Genet; 2005 Jul; 117(2-3):119-32. PubMed ID: 15883839
[TBL] [Abstract][Full Text] [Related]
26. 4843delC of the BRCA1 gene is a possible founder mutation in Southern Italy (Sicily).
Russo A; Calò V; Augello C; Bruno L; Agnese V; Schirò V; Barbera F; Cascio S; Foddai E; Badalamenti G; Intrivici C; Cajozzo M; Gulotta G; Surmacz E; Colucci G; Gebbia N; Bazan V
Ann Oncol; 2007 Jun; 18 Suppl 6():vi99-102. PubMed ID: 17591844
[TBL] [Abstract][Full Text] [Related]
27. Analysis of BRCA1 and BRCA2 genes in Spanish breast/ovarian cancer patients: a high proportion of mutations unique to Spain and evidence of founder effects.
Díez O; Osorio A; Durán M; Martinez-Ferrandis JI; de la Hoya M; Salazar R; Vega A; Campos B; Rodríguez-López R; Velasco E; Chaves J; Díaz-Rubio E; Jesús Cruz J; Torres M; Esteban E; Cervantes A; Alonso C; San Román JM; González-Sarmiento R; Miner C; Carracedo A; Eugenia Armengod M; Caldés T; Benítez J; Baiget M
Hum Mutat; 2003 Oct; 22(4):301-12. PubMed ID: 12955716
[TBL] [Abstract][Full Text] [Related]
28. The R71G BRCA1 is a founder Spanish mutation and leads to aberrant splicing of the transcript.
Vega A; Campos B; Bressac-De-Paillerets B; Bond PM; Janin N; Douglas FS; Domènech M; Baena M; Pericay C; Alonso C; Carracedo A; Baiget M; Diez O
Hum Mutat; 2001 Jun; 17(6):520-1. PubMed ID: 11385711
[TBL] [Abstract][Full Text] [Related]
29. Screening for a BRCA2 rearrangement in high-risk breast/ovarian cancer families: evidence for a founder effect and analysis of the associated phenotypes.
Machado PM; Brandão RD; Cavaco BM; Eugénio J; Bento S; Nave M; Rodrigues P; Fernandes A; Vaz F
J Clin Oncol; 2007 May; 25(15):2027-34. PubMed ID: 17513806
[TBL] [Abstract][Full Text] [Related]
30. Founder effect of the BRCA1 5382insC mutation in Brazilian patients with hereditary breast ovary cancer syndrome.
da Costa EC; Vargas FR; Moreira AS; Lourenço JJ; Caleffi M; Ashton-Prolla P; Martins Moreira MA
Cancer Genet Cytogenet; 2008 Jul; 184(1):62-6. PubMed ID: 18558292
[TBL] [Abstract][Full Text] [Related]
31. Haplotype analysis suggest common founders in carriers of the recurrent BRCA2 mutation, 3398delAAAAG, in French Canadian hereditary breast and/ovarian cancer families.
Oros KK; Leblanc G; Arcand SL; Shen Z; Perret C; Mes-Masson AM; Foulkes WD; Ghadirian P; Provencher D; Tonin PN
BMC Med Genet; 2006 Mar; 7():23. PubMed ID: 16539696
[TBL] [Abstract][Full Text] [Related]
32. The contribution of founder mutations in BRCA1 to breast cancer in Belarus.
Uglanitsa N; Oszurek O; Uglanitsa K; Savonievich E; Lubiński J; Cybulski C; Debniak T; Narod SA; Gronwald J
Clin Genet; 2010 Oct; 78(4):377-80. PubMed ID: 20507347
[TBL] [Abstract][Full Text] [Related]
33. A high occurrence of BRCA1 and BRCA2 mutations among Czech hereditary breast and breast-ovarian cancer families.
Machácková E; Foretová L; Navrátilová M; Valík D; Claes K; Messiaen L
Cas Lek Cesk; 2000 Oct; 139(20):635-7. PubMed ID: 11192759
[TBL] [Abstract][Full Text] [Related]
34. Absence of genomic BRCA1 and BRCA2 rearrangements in Ashkenazi breast and ovarian cancer families.
Stadler ZK; Saloustros E; Hansen NA; Schluger AE; Kauff ND; Offit K; Robson ME
Breast Cancer Res Treat; 2010 Sep; 123(2):581-5. PubMed ID: 20221693
[TBL] [Abstract][Full Text] [Related]
35. A high proportion of founder BRCA1 mutations in Polish breast cancer families.
Górski B; Jakubowska A; Huzarski T; Byrski T; Gronwald J; Grzybowska E; Mackiewicz A; Stawicka M; Bebenek M; Sorokin D; Fiszer-Maliszewska Ł; Haus O; Janiszewska H; Niepsuj S; Góźdź S; Zaremba L; Posmyk M; Płuzańska M; Kilar E; Czudowska D; Waśko B; Miturski R; Kowalczyk JR; Urbański K; Szwiec M; Koc J; Debniak B; Rozmiarek A; Debniak T; Cybulski C; Kowalska E; Tołoczko-Grabarek A; Zajaczek S; Menkiszak J; Medrek K; Masojć B; Mierzejewski M; Narod SA; Lubiński J
Int J Cancer; 2004 Jul; 110(5):683-6. PubMed ID: 15146557
[TBL] [Abstract][Full Text] [Related]
36. BRCA1 germline mutational spectrum in Italian families from Tuscany: a high frequency of novel mutations.
Caligo MA; Ghimenti C; Cipollini G; Ricci S; Brunetti I; Marchetti V; Olsen R; Neuhausen S; Shattuck-Eidens D; Conte PF; Skolnick MH; Bevilacqua G
Oncogene; 1996 Oct; 13(7):1483-8. PubMed ID: 8875986
[TBL] [Abstract][Full Text] [Related]
37. [The limited spectrum of pathogenic BRCA1 and BRCA2 mutations in the French Canadian breast and breast-ovarian cancer families, a founder population of Quebec, Canada].
Tonin PN
Bull Cancer; 2006 Sep; 93(9):841-6. PubMed ID: 16980226
[TBL] [Abstract][Full Text] [Related]
38. A novel BRCA-1 mutation in Arab kindred from east Jerusalem with breast and ovarian cancer.
Kadouri L; Bercovich D; Elimelech A; Lerer I; Sagi M; Glusman G; Shochat C; Korem S; Hamburger T; Nissan A; Abu-Halaf N; Badrriyah M; Abeliovich D; Peretz T
BMC Cancer; 2007 Jan; 7():14. PubMed ID: 17233897
[TBL] [Abstract][Full Text] [Related]
39. A founder mutation of the BRCA1 gene in Western Sweden associated with a high incidence of breast and ovarian cancer.
Einbeigi Z; Bergman A; Kindblom LG; Martinsson T; Meis-Kindblom JM; Nordling M; Suurküla M; Wahlström J; Wallgren A; Karlsson P
Eur J Cancer; 2001 Oct; 37(15):1904-9. PubMed ID: 11576847
[TBL] [Abstract][Full Text] [Related]
40. Haplotype analysis of the BRCA2 9254delATCAT recurrent mutation in breast/ovarian cancer families from Spain.
Campos B; Díez O; Odefrey F; Domènech M; Moncoutier V; Martínez-Ferrandis JI; Osorio A; Balmaña J; Barroso A; Armengod ME; Benítez J; Alonso C; Stoppa-Lyonnet D; Goldgar D; Baiget M
Hum Mutat; 2003 Apr; 21(4):452. PubMed ID: 12655574
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
